Amanote Research

Amanote Research

    RegisterSign In

A Major Role of TWEAK/Fn14 Axis as a Therapeutic Target for Post-Angioplasty Restenosis

EBioMedicine - Netherlands
doi 10.1016/j.ebiom.2019.07.072
Full Text
Open PDF
Abstract

Available in full text

Categories
BiochemistryMedicineGeneticsMolecular Biology
Date

August 1, 2019

Authors
Nerea Méndez-BarberoCarmen Gutierrez-MuñozJulio Madrigal-MatutePablo MínguezJesús EgidoJean-Baptiste MichelJose L. Martín-VenturaVanesa EstebanLuis M. Blanco-Colio
Publisher

Elsevier BV


Related search

The TWEAK-Fn14 System as a Potential Drug Target

British Journal of Pharmacology
Pharmacology
2013English

A Crucial Role of MafA as a Novel Therapeutic Target for Diabetes

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2005English

Angioplasty and Restenosis.

BMJ
1991English

LncRNA as a Therapeutic Target for Angiogenesis

Current Topics in Medicinal Chemistry
MedicineDrug Discovery
2017English

The Elabela-Apj Axis: A Promising Therapeutic Target for Heart Failure

Heart Failure Reviews
Cardiovascular MedicineCardiology
2020English

Lysosomes as a Therapeutic Target

Nature Reviews Drug Discovery
MedicineDrug DiscoveryPharmacology
2019English

Preventing Restenosis After Angioplasty: A Multistage Approach

Clinical Science
Medicine
2008English

CD38 as a Therapeutic Target

Molecular Medicine
Molecular MedicineGeneticsMolecular Biology
2006English

TIMP-3 as a Therapeutic Target for Cancer

Therapeutic Advances in Medical Oncology
Oncology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy